Bora Pharmaceuticals Beheer
Beheer criteriumcontroles 2/4
Momenteel beschikken wij niet over voldoende informatie over de CEO.
Belangrijke informatie
Bobby Sheng
Algemeen directeur
n/a
Totale compensatie
| Percentage CEO-salaris | n/a |
| Dienstverband CEO | 10.3yrs |
| Eigendom CEO | 6.7% |
| Management gemiddelde ambtstermijn | 7.2yrs |
| Gemiddelde ambtstermijn bestuur | 8.5yrs |
Recente managementupdates
Recent updates
Bora Pharmaceuticals' (TWSE:6472) Earnings Are Weaker Than They Seem
Nov 21
Does Bora Pharmaceuticals (TWSE:6472) Deserve A Spot On Your Watchlist?
Oct 04Investors Appear Satisfied With Bora Pharmaceuticals Co., LTD.'s (TWSE:6472) Prospects
Jul 18Is Bora Pharmaceuticals Co., LTD. (TWSE:6472) Trading At A 44% Discount?
Jun 13Bora Pharmaceuticals Co., LTD. (TWSE:6472) Stock Rockets 33% As Investors Are Less Pessimistic Than Expected
Apr 10Bora Pharmaceuticals (TWSE:6472) Could Easily Take On More Debt
Apr 08Shareholders Can Be Confident That Bora Pharmaceuticals' (TWSE:6472) Earnings Are High Quality
Mar 14Is Bora Pharmaceuticals (GTSM:6472) A Risky Investment?
Apr 30Are Strong Financial Prospects The Force That Is Driving The Momentum In Bora Pharmaceuticals Co., LTD.'s GTSM:6472) Stock?
Mar 17Bora Pharmaceuticals (GTSM:6472) Has Rewarded Shareholders With An Exceptional 695% Total Return On Their Investment
Feb 17
New Forecasts: Here's What Analysts Think The Future Holds For Bora Pharmaceuticals Co., LTD. (GTSM:6472)
Jan 27Bora Pharmaceuticals (GTSM:6472) Takes On Some Risk With Its Use Of Debt
Jan 19We're Not So Sure You Should Rely on Bora Pharmaceuticals's (GTSM:6472) Statutory Earnings
Dec 29Are Robust Financials Driving The Recent Rally In Bora Pharmaceuticals Co., LTD.'s (GTSM:6472) Stock?
Dec 09CEO
Bobby Sheng
10.3yrs
Tenure
Mr. Pao-Shi Sheng, also known as Bobby, serves as Chairman of the Board at SunWay Biotech Co. LTD. since 2024. He Founder of Earth 88 and serves as its Chief Executive Officer.He serves as an Independent...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Chairman | no data | geen gegevens | 6.72% NT$ 5.4b | |
| CFO of HQ & APAC | 11.8yrs | geen gegevens | geen gegevens | |
| Corporate Human Resource Director | 2.8yrs | geen gegevens | geen gegevens | |
| VP & Director | 11.6yrs | geen gegevens | 1.04% NT$ 834.2m | |
| Senior VP of Marketing and Sales - CDMO Business | no data | geen gegevens | geen gegevens | |
| CFO of North America | no data | geen gegevens | geen gegevens | |
| Senior Vice President of Taiwan Site Operations | 1.8yrs | geen gegevens | geen gegevens | |
| Deputy General Manager | no data | geen gegevens | 0.0099% NT$ 8.0m | |
| Deputy General Manager | no data | geen gegevens | 0.067% NT$ 54.1m |
7.2yrs
Gemiddelde duur
Ervaren management: Het managementteam van 6472 is doorgewinterd en ervaren (gemiddelde ambtstermijn van 7.2 jaar).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Chairman | 10.3yrs | geen gegevens | 6.72% NT$ 5.4b | |
| VP & Director | 10.3yrs | geen gegevens | 1.04% NT$ 834.2m | |
| Independent Director | 9.6yrs | geen gegevens | geen gegevens | |
| Director | 10.3yrs | geen gegevens | geen gegevens | |
| Director | 5.4yrs | geen gegevens | geen gegevens | |
| Independent Director | 7.4yrs | geen gegevens | geen gegevens | |
| Independent Director | 7.4yrs | geen gegevens | 0.028% NT$ 22.8m | |
| Independent Director | 1.4yrs | geen gegevens | 0% NT$ 0 |
8.5yrs
Gemiddelde duur
Ervaren bestuur: De raad van bestuur van 6472 wordt beschouwd als ervaren (gemiddelde ambtstermijn 8.5 jaar).